{
    "pmcid": "9482557",
    "qa_pairs": {
        "How can nanobodies be engineered to enhance their neutralization potency, as described in the paper?": [
            "By multimerization into formats like dimers or trimers",
            "By increasing their molecular weight",
            "By reducing their solubility",
            "By decreasing their stability"
        ],
        "What advantage do nanobodies have due to their small size as mentioned in the paper?": [
            "Efficient tissue penetration and access to cryptic epitopes",
            "Increased immunogenicity",
            "Higher molecular weight",
            "Reduced solubility"
        ],
        "What is one potential application of nanobodies due to their stability and small size, as highlighted in the paper?": [
            "Formulation for inhalation to provide direct delivery to the respiratory tract",
            "Use as a vaccine adjuvant",
            "Integration into mRNA vaccines",
            "Development of oral tablets"
        ],
        "What is the primary target for nanobodies in combating SARS-CoV-2 according to the paper?": [
            "The receptor-binding domain (RBD) of the spike protein",
            "The nucleocapsid protein",
            "The membrane protein",
            "The envelope protein"
        ],
        "What method is used to rapidly identify nanobodies with high affinity for the SARS-CoV-2 RBD?": [
            "Phage display and surface display technologies",
            "Western blotting",
            "ELISA",
            "Flow cytometry"
        ]
    }
}